Overexpression of NAD(P)H:quinone Oxidoreductase 1 in Human Reproductive System
暂无分享,去创建一个
[1] J. Radford,et al. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Ross,et al. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] D. Ross,et al. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] D. Ross,et al. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. , 1995, Molecular pharmacology.
[5] D. Ross,et al. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. , 1994, Oncology research.
[6] Meistrich Ml. Effects of chemotherapy and radiotherapy on spermatogenesis. , 1993 .
[7] M. Meistrich,et al. Effects of chemotherapy and radiotherapy on spermatogenesis. , 1993, European urology.